Le Lézard
Classified in: Science and technology, Business
Subjects: NEW PRODUCTS/SERVICES, BUSINESS CONTRACTS

Nubeva Provides Customer Update


SAN JOSE, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Nubeva Technologies (TSX-V: NBVA, OTCQB: NBVAF)("Nubeva" or the "Company") announces Kroll, LLC ("Kroll") has terminated its relationship with the Company in respect of all use cases, more particularly described in the Company's news releases of December 5, 2022, January 4, 2023, January 23, 2023 and March 2, 2023. Company revenue related to its relationship with Kroll comprised 86% of total revenue for the Company's 2023 fiscal year. The Company looks forward to continuing to diversify its customer base with additional engagements in fiscal 2024, including the three-year, US$1,700,000 contract announced on June 7, 2023.

About Nubeva Technologies

Nubeva Technologies provides next-generation decryption solutions for faster, lower-cost recovery from ransomware attacks. Its mission is to reduce downtime costs and damages so businesses never pay ransoms again.

Nubeva's ransomware reversal software is available to end-user enterprises, managed security service providers, incident responders, and cybersecurity solution manufacturers. For a private briefing on Nubeva's ransomware reversal and retrieval abilities, Contact Us.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, products, and the outlook of the cybersecurity industry. Although the Company believes in light of the experience of its officers and directors, current conditions and expected future developments, and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements for reasons relating to the development and adoption of the Company's technology, and its input and capital cost requirements, among other factors discussed in the Company's continuous disclosure filings, available at www.sedarplus.com. The statements in this press release are made as of the date of this release, and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations, or statements made by third parties regarding the Company, its subsidiaries, their securities, or their respective financial or operating results (as applicable).

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For additional information or to schedule interviews, contact:

Randy Chou
[email protected]
844.538.4638

 



These press releases may also interest you

at 13:50
Ernst & Young LLP (EY US) today announced that Michael Kopko, CEO and co-Founder of Pearl Health, was named an Entrepreneur Of The Year® 2024 New York Award winner. Entrepreneur Of The Year is the preeminent competitive awards program for...

at 13:48
Directions Inc, a leading insights and intelligence firm, recently held its highly anticipated annual company meeting where incoming President and CEO Elizabeth (Beth) Finn unveiled her vision for the firm's future. Beth was recently selected by the...

at 13:45
The Public Inquiry into Foreign Interference in Federal Electoral Processes and Democratic Institutions has expanded its public consultation process by adding content to its website in 17 additional languages....

at 13:41
Constella Intelligence ("Constella") proudly introduced its Advanced Know Your Business (KYB) solution, a pioneering leap in external identity risk management that builds upon its established Know Your Employee (KYE) capabilities. Constella's...

at 13:38
Central Contra Costa Sanitary District (Central San) and nationwide solar provider REC Solar announce the completion of a 2.16 megawatt (MW) solar array near Central San's treatment plant in Martinez, Calif....

at 13:38
Kanvas Biosciences, a full-stack spatial biology company, today introduced its newest drug candidate in its Immuno-oncology Program: KAN-003. The Kanvas platform provides the unique ability to map host-microbiome interactions and leverage the...



News published on and distributed by: